Primary Cells

Human Mobilized Peripheral Blood Mononuclear Cells, CD34 Depleted

  • For research use only

Cat No.

ABC-TC3707

Product Type

Normal Human Peripheral Blood Mononuclear Cells

Cell Type

Mononuclear Cell

Species

Human

Growth Conditions

37 ℃, 5% CO2

Source Organ

Peripheral Blood

Disease

Normal

Storage

Liquid Nitrogen

Human Mobilized PBMCs, CD34 Depleted support immune response modeling and hematopoietic cell research without progenitor or stem cell interference.

Product Image

Description

Human Mobilized Peripheral Blood Mononuclear Cells (PBMCs), CD34-Depleted are immunocompetent PBMCs isolated from G-CSF-mobilized peripheral blood following selective removal of CD34⁺ hematopoietic stem/progenitor cells. This specialized product retains the complete diversity of immune cell populations (T cells, B cells, NK cells, monocytes, dendritic cells) while eliminating hematopoietic precursors, making it ideal for immunotherapy research and immune function studies. They express typical surface markers such as CD3 (T cells), CD19 (B cells), CD56 (NK cells), and CD14 (monocytes) while CD34⁺ cells is specifically depleted. The mobilized PBMCs exhibit enhanced immune cell activation potential compared to steady-state blood due to the mobilization process, while the CD34 depletion ensures no interference from progenitor cells in experimental outcomes. Accordingly, these cells are widely used for immune cell profiling, evaluation of mobilization and CD34 depletion effects, lymphocyte enrichment, and immune-focused experimental workflows.

Species

Human

Cat.No

ABC-TC3707

Product Category

Primary Cells

Size/Quantity

1 vial

Cell Type

Mononuclear Cell

Growth Mode

Adherent

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Peripheral Blood

Disease

Normal

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Normal Human Peripheral Blood Mononuclear Cells

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Application

  • Human Mobilized Peripheral Blood Mononuclear Cells (PBMCs), CD34 Depleted can be used to study non-hematopoietic stem cell-mediated immune regulation mechanisms, such as graft-versus-host disease (GVHD), autoimmune diseases (such as rheumatoid arthritis) and tumor immunotherapy (such as CAR-T cell therapy). These cells can also be used to explore the pathological mechanisms related to abnormal activation or functional defects of immune cells, and provide an experimental basis for the treatment strategy of immune-related diseases.

Citation

When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Inquiring Human Mobilized Peripheral Blood Mononuclear Cells, CD34 Depleted

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button